RadNet, Inc. (RDNT)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$73.71-1.22%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · RDNT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 2,268.9 | 2,040.2 | 1,829.7 | 1,616.6 | 1,430.1 | 1,315.1 | 1,071.8 | 1,154.2 | 975.1 | 922.2 | 884.5 | 809.6 | 717.6 | 703.0 | 85.0 | 585.1 |
| Total Revenues | — | — | — | 1,616.6 | 1,430.1 | 1,315.1 | 1,071.8 | 1,154.2 | 975.1 | 922.2 | 884.5 | 809.6 | 717.6 | 703.0 | 85.0 | 585.1 |
| Cost of Revenues | — | — | — | — | — | — | — | 999.7 | 867.5 | 802.4 | 775.8 | 708.3 | 36.8 | 38.2 | 38.2 | 31.6 |
| Operating Expenses & Income | ||||||||||||||||
| Operating Income | 70.8 | 62.0 | 104.6 | 98.7 | 46.4 | 82.6 | 35.7 | 69.9 | 30.9 | 50.1 | 38.5 | 39.1 | 10.7 | 11.6 | 12.6 | 8.4 |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | — |
| Interest & Investment Income | 25.6 | 31.9 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | (35.8) | (30.1) | (59.8) | (59.9) | (3.4) | (23.7) | (36.5) | (40.2) | 7.6 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 35.0 | 31.9 | 44.9 | 38.8 | 43.0 | 58.9 | (0.9) | 29.7 | 38.5 | 26.4 | 12.4 | 14.6 | 3.7 | 5.9 | 4.4 | 8.2 |
| Income Tax Expense | 15.7 | 14.9 | 6.0 | 8.5 | 9.4 | 14.6 | 0.9 | 6.2 | 0.4 | 24.3 | 4.4 | 6.0 | 2.0 | 3.5 | (55.2) | 0.8 |
| Net Income | ||||||||||||||||
| Minority Interest | 40.4 | 35.7 | 36.0 | 27.3 | 23.0 | 19.6 | 13.1 | 8.7 | 5.9 | 2.0 | 0.8 | 0.9 | 0.3 | 0.3 | (0.2) | 0.1 |
| Net Income | (21.1) | (18.7) | 2.8 | 3.0 | 10.7 | 24.7 | (14.8) | 14.8 | 32.2 | 0.1 | 7.2 | 7.7 | 10.7 | 11.5 | 12.4 | 8.0 |
| Per Share | ||||||||||||||||
| Basic EPS | (0.27) | (0.25) | 0.04 | 0.05 | 0.19 | 0.47 | (0.29) | 0.30 | 0.67 | 0.00 | 0.16 | 0.18 | 0.03 | 0.05 | 1.58 | 0.19 |
| Diluted EPS | (0.27) | (0.25) | 0.04 | 0.05 | 0.17 | 0.46 | (0.29) | 0.29 | 0.66 | 0.00 | 0.15 | 0.17 | 0.03 | 0.05 | 1.52 | 0.19 |
| Revenue per Share | 28.82 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 77.8 | 75.2 | 73.0 | 63.6 | 56.3 | 52.5 | 50.9 | 49.7 | 48.1 | 46.9 | 46.2 | 43.8 | 41.1 | 39.1 | 37.8 | 37.4 |
| Diluted Weighted Avg Shares | 78.7 | 75.2 | 74.8 | 64.7 | 57.3 | 53.4 | 50.9 | 50.2 | 48.7 | 47.4 | 46.7 | 45.2 | 43.1 | 39.8 | 39.2 | 38.8 |
| Supplemental | ||||||||||||||||
| EBITDA | — | 198.1 | 229.9 | 214.9 | 152.0 | 174.9 | 118.8 | 147.4 | 101.1 | 114.3 | 102.5 | 96.7 | 15.4 | 16.2 | 17.2 | 62.4 |
| EBIT | 70.8 | 62.0 | 104.6 | 98.7 | 46.4 | 82.6 | 35.7 | 69.9 | 30.9 | 50.1 | 38.5 | 39.1 | 10.7 | 11.6 | 12.6 | 8.4 |
| Effective Tax Rate | 44.9% | — | — | 21.8% | 21.8% | 24.7% | -104.8% | 21.0% | 1.0% | 92.1% | 35.6% | 41.0% | 53.9% | 59.6% | -1261.8% | 10.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.